Frost & Sullivan Reveals Five Patient Monitoring Solutions to Accelerate Universal Health Coverage
Patient monitoring helps patients have better outcomes and live longer
Santa Clara, Calif. - April 8, 2019 (Investorideas.com Newswire) Today is World Health Day, and this year's theme is "Universal Health Coverage: Everyone, Everywhere-#HealthforAll." An important aspect of "Health for All" is the role of technology, particularly patient monitoring (PM), which helps patients have better outcomes and live longer, healthier lives, even when access to hospitals and clinics is challenging.
Patient monitoring has evolved from ad hoc to continuous monitoring of multiple parameters, causing a surge in the amount of unprocessed and unorganized data available to clinicians for decision-making. To extract actionable information from this data, healthcare providers are turning to big data analytics and other analysis solutions. Predictive analytics is becoming a particularly important technology, as it not only presents the current state of the patient's health but also predicts future illnesses. The success of this technology, among many others, attracted $566.3 million in investments in 2018.
For further information on this analysis or to schedule an interview, please contact firstname.lastname@example.org
"As mHealth rapidly gains traction, wearables, telehealth, social media, and patient engagement are expected to find adoption among more than half of the population in developed economies by 2025," said Sowmya Rajagopalan, Advanced Medical Technologies Global Director. "The patient monitoring market is expected to be worth more than $350 billion by 2025, as the focus is likely to move beyond device sales to solutions."
Frost & Sullivan's recent analysis, Patient Monitoring Industry-Analysis of Investment and Trends, 2018, offers an overview of the current investment trends and start-ups in select patient monitoring applications. It studies the future of patient monitoring across the continuum of care, the shifts in the market, and investment opportunities. It also presents the key disruptive technologies, application areas, drivers, restraints, as well as the top six Mega Trends.
"In the future, patient monitoring data will be combined with concurrent streams from numerous other sensors, as almost every life function will be monitored and its data captured and stored," noted Rajagopalan. "The data explosion can be harnessed and employed through technologies such as Artificial Intelligence (AI), machine learning, etc., to deliver targeted, outcome-based therapies."
In addition to these technologies, patient monitoring solution developers will look to incorporate disruptive technologies such as:
- Brain-computer interface (BCI): From treating and monitoring users with mobility or speech disabilities, BCI now monitors and measures health metrics for healthy people and uses the information to analyze a person's psychological state or emotional, cognitive state.
- Wearables/Embedded/Biosensors: An increase in the chronic disease population and shift in focus from treatment to prevention drive this technology. Continuous glucose monitors, blood pressure monitors, pulse oximeters, and electrocardiogram monitors are some of the main applications.
- Smart Prosthetics/Smart Implants: These are crucial for patient management post-surgery or rehabilitation. They help in measuring the key parameters to support monitoring and early intervention to avoid readmission or complexities.
- Nano-robotics/Digital Medicine: Digital pills and nanorobots are designed to monitor medicine intake to address the expensive, long-standing issue of non-adherence.
- Advanced Materials/Smart Fabrics: This emerging field focuses on wound management, cardiac monitoring, and mental illness.
All these technologies and innovations are focused on providing real-time measurable value to the patient and healthcare institution. Future innovations will be aimed at mass personalization and availability.
Patient Monitoring Industry-Analysis of Investment and Trends, 2018 is part of Frost & Sullivan's global Advanced Medical Technologies Growth Partnership Service program.
About Frost & Sullivan
For over five decades, Frost & Sullivan has become world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.
Patient Monitoring Industry-Analysis of Investment and Trends, 2018 9AB9-48
T: +1 210 348 10 12
T: +54 11 4778 3540
This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release on the Investorideas.com newswire https://www.investorideas.com/News-Upload/
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.